VENXXIVA™ (tiopronin) Delayed-Release Tablets

Helping you and your patients manage life’s complexities.

VENXXIVA is a proven treatment for patients with cystinuria. accompanied by our patient support program, Cycle Vita™. VENXXIVA can help your patients find relief by reducing the frequency and severity of stone formation.1

VENXXIVA is available in 100 mg and 300 mg dose strengths, which could reduce pill burden by up to two-thirds for your patients.2

Find out moreEnroll your patients

NOT ACTUAL PATIENTS

NOT ACTUAL PATIENTS

Product

VENXXIVA works by maintaining low cystine concentration in the urine to prevent stone formation. Patients should take VENXXIVA alongside high fluid intake, alkali and diet modifications.2

HCP Icon
FDA-approved
Medication Icon
Available in 100 mg and 300 mg doses2
Person Icon
The same proven tiopronin your patients may be familiar with
Apple Icon
VENXXIVA (tiopronin) Delayed-Release Tablets must be taken without food2
Learn more about VENXXIVA

Support

We know that life-changing treatments need a support system which is tailored to the unique challenges your patients face. That’s why we created Cycle Vita, our dedicated patient support program, which delivers individualized product support* at every step. Including:

Medication Form Icon
Bridge Program
Care Icon
Continuous Product and Process Support
Payment Icon
Financial Assistance
Food Approve Icon
Patient Nutrition Program
Learn more about Cycle Vita

*Some areas of support may not be accessible to all patients. Eligibility criteria may apply to ensure compliance with all applicable federal and state requirements, and benefits may be limited to commercially insured patients only. For more detailed information about eligibility, terms and conditions, please contact the Cycle Vita team at 888-360-8482.

References

  1. Pak et al., 2018. The Journal of Urology. Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine. 136(5):1003-8. DOI: 10.1016/s0022-5347(17)45188-3 [Accessed: September 10 2024].
  2. VENXXIVA (tiopronin) Delayed-Release Tablets. Prescribing Information. Torrent Pharma Inc.